- >
- Investors
Presentation
91直播 is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.
91直播 is a French clinical-stage biotech company. The core activities of the company are to innovate, to discover and to develop new therapeutic solutions to improve the lives of people suffering from chronic metabolic diseases, such as diabetes and obesity.
ADOCIAADOC.PA
3,99%6,52 鈧�
Source: Forex
Latest press releases
ADOCIA Announces its Financial Calendar for 2026
12/18/2025
ADOCIA Announces the Completion of a 鈧�10 Million Fundraising
12/04/2025
ADOCIA Announces Filing of Patent for New Long-Acting Peptides Platform in Diabetes and Obesity – AdoXLong – and Provides an Update on its BioChaperone庐 Platform
11/12/2025
